Literature DB >> 12106302

Reduction of Potassium Conductances Mediated by Metabotropic Glutamate Receptors in Rat CA3 Pyramidal Cells Does Not Require Protein Kinase C or Protein Kinase A.

U. Gerber1, J. A. Sim, B. H. Gähwiler.   

Abstract

Metabotropic glutamate receptors, unlike ionotropic receptors, exert their actions on ion channels via G-proteins coupled to second messenger systems. In the hippocampus stimulation of metabotropic receptors can lead to decreased potassium channel conductance, decreased accommodation of cell firing and inhibition of the slow calcium-dependent afterhyperpolarizing current (IAHP). Using the single-electrode voltage-clamp technique in hippocampal slice cultures of the rat, the role of protein kinases in mediating these metabotropic glutamate responses was investigated. In the presence of staurosporin, protein kinase C activation by phorbol esters and protein kinase A activation by 8-bromo-cyclic adenosine monophosphate were blocked. Under these conditions, the inhibition of IAHP by 1-amino-cyclopentyl-trans-dicarboxylate (ACPD), a metabotropic agonist, was unchanged, whilst the inward current elicited by ACPD was enhanced. These results demonstrate that, in the hippocampus, metabotropic glutamate responses persist during inhibition of protein kinase A and C activation. Furthermore, these responses are insensitive to pertussis toxin, confirming previous observations.

Entities:  

Year:  1992        PMID: 12106302     DOI: 10.1111/j.1460-9568.1992.tb00189.x

Source DB:  PubMed          Journal:  Eur J Neurosci        ISSN: 0953-816X            Impact factor:   3.386


  9 in total

1.  Functional specificity of G alpha q and G alpha 11 in the cholinergic and glutamatergic modulation of potassium currents and excitability in hippocampal neurons.

Authors:  Michael Krause; Stefan Offermanns; Martin Stocker; Paola Pedarzani
Journal:  J Neurosci       Date:  2002-02-01       Impact factor: 6.167

2.  Protein kinase A-independent modulation of ion channels in the brain by cyclic AMP.

Authors:  P Pedarzani; J F Storm
Journal:  Proc Natl Acad Sci U S A       Date:  1995-12-05       Impact factor: 11.205

3.  Age-related enhancement of the slow outward calcium-activated potassium current in hippocampal CA1 pyramidal neurons in vitro.

Authors:  John M Power; Wendy W Wu; Evgeny Sametsky; M Mathew Oh; John F Disterhoft
Journal:  J Neurosci       Date:  2002-08-15       Impact factor: 6.167

4.  Signal transduction pathways involved in the acute potentiation of NMDA responses by 1S,3R-ACPD in rat hippocampal slices.

Authors:  J Harvey; G L Collingridge
Journal:  Br J Pharmacol       Date:  1993-08       Impact factor: 8.739

5.  Ischemia-reperfusion injury of the cochlea: pharmacological strategies for cochlear protection and implications of glutamate and reactive oxygen species.

Authors:  Keiji Tabuchi; Bungo Nishimura; Shuho Tanaka; Kentaro Hayashi; Yuki Hirose; Akira Hara
Journal:  Curr Neuropharmacol       Date:  2010-06       Impact factor: 7.363

6.  Modulation of afterpotentials and firing pattern in guinea pig CA3 neurones by group I metabotropic glutamate receptors.

Authors:  Steven R Young; Shih-Chieh Chuang; Robert K S Wong
Journal:  J Physiol       Date:  2003-10-24       Impact factor: 5.182

7.  Cyclic AMP-dependent modulation of giant depolarizing potentials by metabotropic glutamate receptors in the rat hippocampus.

Authors:  F Strata; M Sciancalepore; E Cherubini
Journal:  J Physiol       Date:  1995-11-15       Impact factor: 5.182

8.  Evidence that Ca/calmodulin-dependent protein kinase mediates the modulation of the Ca2+-dependent K+ current, IAHP, by acetylcholine, but not by glutamate, in hippocampal neurons.

Authors:  P Pedarzani; J F Storm
Journal:  Pflugers Arch       Date:  1996-03       Impact factor: 3.657

9.  Reduction of resting K+ current by metabotropic glutamate and muscarinic receptors in rat CA3 cells: mediation by G-proteins.

Authors:  N C Guérineau; B H Gähwiler; U Gerber
Journal:  J Physiol       Date:  1994-01-01       Impact factor: 5.182

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.